Your session is about to expire
← Back to Search
Etrasimod for Eczema
Study Summary
This trial is testing the safety and effectiveness of etrasimod, a pill taken once daily, to treat moderate-to-severe atopic dermatitis (eczema) in adults who tried treatments that work all over the body and saw no effects. Participants will visit the clinic 6-12 times over 16-68 weeks, with tests for signs/symptoms, blood samples and vital signs.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have been diagnosed with chronic eczema for over a year.I am between 18 and 80 years old.I do not have a serious infection or need treatment for one that could affect the trial.My eczema is moderate to severe, covering more than 10% of my body.I have tried a treatment for my condition before and it didn't work.You are allergic to etrasimod or any of the ingredients in the medication.You have a medical or mental health condition, or recent thoughts of hurting yourself, that could make it risky for you to join the study.I am willing to apply a skin moisturizer daily for at least one week before the study starts and will continue to do so throughout the study.I do not have skin conditions like psoriasis that could affect my treatment evaluation.
- Group 1: etrasimod
- Group 2: Placebo (Part 1 DB period only)
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this research require participants to be of legal age?
"The qualifications for this medical trial necessitate that participants lie between 18 and 80 years old. There are 105 trials dedicated to minors under the age of 18, and 170 specifically catering towards seniors over 65 years in age."
Does my background qualify me to partake in this experiment?
"The requirements to be admitted into this medical trial include having a diagnosis of atopic dermatitis and being between 18-80 years old. There is capacity for approximately 400 individuals to participate."
How many venues are currently hosting this clinical trial?
"Akumin Imaging in Tampa, Michigan, Clinical Research Trials of Florida in Lathrup Village, South dakota, and Tampa Eye Clinic in Troy, Texas are among the 10 clinical sites administering this trial."
What is the present size of this research project's participant population?
"This study necessitates the inclusion of 400 eligible patients. Participants can enroll at Akumin Imaging in Tampa, Michigan and Clinical Research Trials of Florida in Lathrup Village, South dakota."
Are there any opportunities for patient enrolment in this investigation?
"Clinicaltrials.gov confirms that recruitment for this clinical trial is ongoing, beginning on January 18th 2023 and most recently updated February 7th 2023."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger